In Brief
![](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3-300x300.jpg)
![](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3-300x300.jpg)
Drugs & Targets
In The Clinic
Latest Issue
NEWS ALERTS
Conversations with The Cancer Letter
Contributors
Case Comprehensive Cancer Center
Trending Stories
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- What are you reading in 2023?
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence
Recent Issues
The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.